By therapeutic area




 

Policy and management

| | |




Foundation trusts




Healthcare




Payment by results




Practice-based commissioning




Primary care contracts



   

By therapeutic area

CANCER

view page : 1 | 2 | 3 | 4


Advanced breast cancer: diagnosis and treatment (2009)
This guideline updates and replaces NICE technology appraisal guidance 62 (capecitabine), 54 (vinorelbine) and 30 (taxanes)
(NICE clinical guideline 81)


Advice on the development of low dose rate (permanent seed implant) brachytherapy services for localised prostate cancer in England (2006)
(Department of Health)


Applying high impact changes to cancer care: excellence in cancer care (2005)
(Cancer Services Collaborative Improvement Partnership)


Appraisal consultation document: Glioma (newly diagnosed and high grade) carmustine implants and temozolomide (2006)
(NICE)


AWMSG guidance on Cetuximab (Erbitux) (2006)
(All-Wales Medicines Strategy group guidance)


Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer (2007)
(NICE technology appraisal guidance 118)


Calman Hine report (1995)
(aka Policy framework for commissioning cancer services)
(A report by the expert advisory group on cancer to the chief medical officers of England and Wales)


Cancer 10 years on: improvements across the whole care pathway (2007)
(Health Development Agency)


Cancer atlas of the United Kingdom and Ireland 1991-2000 (2005)
(National Statistics)


Cancer care in the NHS (2005)
(Reform)


Cancer commissioning guidance (2009)
Department of Health


The cancer information maze: report investigating information access for people with cancer (2005)
(Association of the British Pharmaceutical Industry, Cancer BACUP and Ask About Medicines)


Cancer information strategy (2000)


Cancer reform strategy: maintaining momentum, building for the future - first annual report (2008)
Department of Health


Cancer scenarios: an aid to planning cancer services in Scotland in the next decade (2001)
(Scottish Executive)


Cancer in Scotland: action for change (2003)
Annual report


Cancer in Scotland: action for change — fourth monitoring reports (2004)


Cancer in Scotland: sustaining change (2004)


Cancer networks in England (2004)


Cancer prevention (2002)
A resource to support local action in delivering the NHS cancer plan
(Health Development Agency)


Cancer reform strategy (2007)
(Department of Health)


Cancer reform strategy impact assessment (2007)
(Department of Health)


Cancer service improvement programme (2007)
(Scottish Executive)


Cancer waiting targets: a guide (2006)
(Department of Health)


Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma (2007)
(NICE technology appraisal guidance 121)


A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality (2007)
(British Journal of Cancer)


Designed to tackle cancer in Wales (2006)
Targets against cancer until 2015
NHS Wales


Developing, delivering and evaluating cancer nursing services (2002)
Building the evidence base


Diagnosis and management of head and neck cancer (2006)
SIGN guidance 90
(Scottish Intercollegiate Guidelines Network)


Docetaxel for the treatment of hormone-refractory metastatic prostate cancer (2006)
NICE technology appraisal guidance 101


box

Early and locally advanced breast cancer (2009)
(National Institute for Health and Clinical Excellence)

line
An easy guide to breast screening (2007)
(Department of Health)


An easy guide to cervical screening (2007)
(Department of Health)


Ensuring payment by results supports delivery of effective cancer services (2008)
(PA Consulting for the Department of Health)


Epithelial ovarian cancer (2003)
SIGN guidance 75
(Scottish Intercollegiate Guidelines Network)


Epoetin alfa, epoetin beta and darbepoetin alfa for cancer treatment-induced anaemia (2008)
(NICE technology appraisal guidance 142)


Familial breast cancer: the classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care (2006)
Partial update of NICE clinical guideline 14
NICE clinical guideline 41


Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia (2007)
NICE technology appraisal guidance 119


For better, for worse? A review of the care of patients who died within 30 days of receiving systemic anti-cancer therapy (2008)
(National Confidential Enquiry into Patient Outcome and Death)


Formative evaluation of the cancer partnership project (2004)
(Department of Health)


Framework for the development of positron emission tomography (PET) services in England (2005)
(Department of Health)


Future trends and challenges for cancer services in England: a review of literature and policy (2006)
(King's Fund)